Global Galectin 3 Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Galectin 3 Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Galectin 3 Market Size Growth Rate by Product
  • 1.4.2 GAL-300
  • 1.4.3 GRMD-03
  • 1.4.4 ANG-4021
  • 1.4.5 KTI
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global Galectin 3 Market Size Growth Rate by End User
  • 1.5.2 Liver Cirrhosis
  • 1.5.3 Portal Hypertension
  • 1.5.4 Metastatic Melanoma
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Galectin 3 Market Size
  • 2.1.1 Global Galectin 3 Revenue 2014-2025
  • 2.1.2 Global Galectin 3 Sales 2014-2025
• 2.2 Galectin 3 Growth Rate by Regions
  • 2.2.1 Global Galectin 3 Sales by Regions
  • 2.2.2 Global Galectin 3 Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Galectin 3 Sales by Manufacturers
  • 3.1.1 Galectin 3 Sales by Manufacturers
  • 3.1.2 Galectin 3 Sales Market Share by Manufacturers
  • 3.1.3 Global Galectin 3 Market Concentration Ratio (CR5 and HHI)
• 3.2 Galectin 3 Revenue by Manufacturers
  • 3.2.1 Galectin 3 Revenue by Manufacturers (2014-2019)
  • 3.2.2 Galectin 3 Revenue Share by Manufacturers (2014-2019)
• 3.3 Galectin 3 Price by Manufacturers
• 3.4 Galectin 3 Manufacturing Base Distribution, Product Types
  • 3.4.1 Galectin 3 Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Galectin 3 Product Type
  • 3.4.3 Date of International Manufacturers Enter into Galectin 3 Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Galectin 3 Sales by Product
• 4.2 Global Galectin 3 Revenue by Product
• 4.3 Galectin 3 Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Galectin 3 Breakdown Data by End User

6 North America

• 6.1 North America Galectin 3 by Countries
  • 6.1.1 North America Galectin 3 Sales by Countries
  • 6.1.2 North America Galectin 3 Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Galectin 3 by Product
• 6.3 North America Galectin 3 by End User

7 Europe

• 7.1 Europe Galectin 3 by Countries
  • 7.1.1 Europe Galectin 3 Sales by Countries
  • 7.1.2 Europe Galectin 3 Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Galectin 3 by Product
• 7.3 Europe Galectin 3 by End User

8 Asia Pacific

• 8.1 Asia Pacific Galectin 3 by Countries
  • 8.1.1 Asia Pacific Galectin 3 Sales by Countries
  • 8.1.2 Asia Pacific Galectin 3 Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Galectin 3 by Product
• 8.3 Asia Pacific Galectin 3 by End User

9 Central & South America

• 9.1 Central & South America Galectin 3 by Countries
  • 9.1.1 Central & South America Galectin 3 Sales by Countries
  • 9.1.2 Central & South America Galectin 3 Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Galectin 3 by Product
• 9.3 Central & South America Galectin 3 by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Galectin 3 by Countries
  • 10.1.1 Middle East and Africa Galectin 3 Sales by Countries
  • 10.1.2 Middle East and Africa Galectin 3 Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Galectin 3 by Product
• 10.3 Middle East and Africa Galectin 3 by End User

11 Company Profiles

• 11.1 Angion Biomedica Corp
  • 11.1.1 Angion Biomedica Corp Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Angion Biomedica Corp Galectin 3 Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Angion Biomedica Corp Galectin 3 Products Offered
  • 11.1.5 Angion Biomedica Corp Recent Development
• 11.2 Bristol-Myers Squibb Company
  • 11.2.1 Bristol-Myers Squibb Company Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bristol-Myers Squibb Company Galectin 3 Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bristol-Myers Squibb Company Galectin 3 Products Offered
  • 11.2.5 Bristol-Myers Squibb Company Recent Development
• 11.3 Galectin Therapeutics Inc
  • 11.3.1 Galectin Therapeutics Inc Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Galectin Therapeutics Inc Galectin 3 Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Galectin Therapeutics Inc Galectin 3 Products Offered
  • 11.3.5 Galectin Therapeutics Inc Recent Development
• 11.4 GlycoMimetics Inc
  • 11.4.1 GlycoMimetics Inc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 GlycoMimetics Inc Galectin 3 Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 GlycoMimetics Inc Galectin 3 Products Offered
  • 11.4.5 GlycoMimetics Inc Recent Development
• 11.5 iTeos Therapeutics SA
  • 11.5.1 iTeos Therapeutics SA Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 iTeos Therapeutics SA Galectin 3 Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 iTeos Therapeutics SA Galectin 3 Products Offered
  • 11.5.5 iTeos Therapeutics SA Recent Development
• 11.6 MandalMed Inc
  • 11.6.1 MandalMed Inc Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 MandalMed Inc Galectin 3 Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 MandalMed Inc Galectin 3 Products Offered
  • 11.6.5 MandalMed Inc Recent Development

12 Future Forecast

• 12.1 Galectin 3 Market Forecast by Regions
  • 12.1.1 Global Galectin 3 Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Galectin 3 Revenue Forecast by Regions 2019-2025
• 12.2 Galectin 3 Market Forecast by Product
  • 12.2.1 Global Galectin 3 Sales Forecast by Product 2019-2025
  • 12.2.2 Global Galectin 3 Revenue Forecast by Product 2019-2025
• 12.3 Galectin 3 Market Forecast by End User
• 12.4 North America Galectin 3 Forecast
• 12.5 Europe Galectin 3 Forecast
• 12.6 Asia Pacific Galectin 3 Forecast
• 12.7 Central & South America Galectin 3 Forecast
• 12.8 Middle East and Africa Galectin 3 Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Galectin 3 Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details